Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical herbal combination for chronic occupational low back pain
IRCT20200913048700N1Phase 3Completed
- Sponsor
- Goldaru
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of arnica, aconitum, calendula, hypericum perforatum and Ruta graveolens in lumbodynia (LBP) (2 arms), sponsored by Goldaru. Primary endpoints: Pain intensity, Pain frequency and 2 more. Started Mar 2023; status: completed.
02
Drugs
arnicaaconitumcalendulahypericum perforatumRuta graveolens
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on IRCT20200913048700N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200913048700N1.